欧康维视生物-B(01477.HK)发布公告,该集团产品OT-703(ILUVIEN®,氟轻松玻璃体植入剂)(是一款可注射的、非生物降解的氟轻松玻璃体植入剂,用于治疗糖尿病性黄斑水肿(DME))最近已获准于中华人民共和国海南省博鳌乐城国际医疗旅游先行区进行真实世界研究。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.